Doripenem Injectable (Iv) Suppliers & Bulk Manufacturers
Available Forms: Injectable (IV)
Available Strengths: 500 mg, 1 g per vial
Reference Brands: Doribax(US & EU)
Category: Antibiotics
Doripenem inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, causing bacterial lysis and death. It offers broad-spectrum activity against resistant gram-negative bacteria, including Pseudomonas. Benefits include rapid, effective bacterial eradication, high tissue penetration, and once-daily dosing, making it ideal for severe, hospital-based infections. Doripenem Injectable (IV) is available in Injectable (IV) and strengths such as 500 mg, 1 g per vial. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Doripenem Injectable (IV) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Doripenem Injectable (IV) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Doripenem injectable is approved in the EU and US for severe bacterial infections such as pneumonia, intra-abdominal, and urinary tract infections. In the EU, brands like Doribax are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Minocycline Hydrochloride
Strength:
50 mg, 75 mg, 100 mg, 20 mg/m
Form: Tablets/ capsules/ Injectable
Reference Brands: Minocin (USA), Solodyn (USA)
View DetailsTetracycline Hydrochloride
Strength:
250 mg, 500 mg
Form: Tablets, Capsules
Reference Brands: Achromycin (USA)
View DetailsOmadacycline
Strength:
100 mg, 150 mg
Form: Tablet/ Injection
Reference Brands: Nuzyra (USA/EU)
View DetailsNitrofurantoin
Strength:
25 mg, 50 mg, 100 mg
Form: Capsules
Reference Brands: Macrobid (USA), Macrodantin (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers